Rapid diagnostic tests that can help distinguish whether a patient has a viral or bacterial infection have long been viewed ...

Biotia, a company advancing infectious disease diagnostics for challenging infections, today announced the clinical ...

Rapid antimicrobial susceptibility testing of blood cultures is not superior to standard testing in patients with gram-negative bloodstream infections, according to the FAST trial.

A randomized trial involving gram-negative bacterial bloodstream infections found that rapid antibiotic susceptibility testing (AST) was not superior to usual testing in terms of clinical outcomes.

USA antimicrobial susceptibility testing market is characterized by the presence of leading diagnostics and life sciences companies focused on delivering rapid, reliable, and scalable solutions.

A rapid microbiological point-of-care test designed to help GPs identify whether a respiratory infection is caused by a virus ...

McGill researchers have developed a diagnostic system capable of identifying bacteria—and determining which antibiotics can stop them—in just 36 minutes, a major advance in the global effort to curb ...

Antimicrobial susceptibility testing (AST) is a fundamental component of modern clinical microbiology that informs therapeutic decisions and underpins surveillance of antimicrobial resistance. AST ...

Researchers have presented a new method for measuring how effectively antibiotics kill bacteria. Antibiotic-resistant bacteria are one of the biggest health problems of our time. Due to mutations, ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but ...

Manufacturing progress, stability data, and formulation advances are moving Lakewood-Amedex’s lead antimicrobial candidate ...